May 22, 2023
The type 2 diabetes drug Mounjaro (tirzepatide), which is being detailed by Mitsubishi Tanabe Pharma in Japan, was the most heavily promoted drug in March through sales rep face-to-face detailing activities for GPs, according to a monthly Intage survey. Intage’s...read more